Literature DB >> 18601805

Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses.

Laura Koopman1, Geert J M G van der Heijden, Arno W Hoes, Diederick E Grobbee, Maroeska M Rovers.   

Abstract

OBJECTIVES: Individual patient data (IPD) meta-analyses have been proposed as a major improvement in meta-analytic methods to study subgroup effects. Subgroup effects of conventional and IPD meta-analyses using identical data have not been compared. Our objective is to compare such subgroup effects using the data of six trials (n = 1,643) on the effectiveness of antibiotics in children with acute otitis media (AOM).
METHODS: Effects (relative risks, risk differences [RD], and their confidence intervals [CI]) of antibiotics in subgroups of children with AOM resulting from (i) conventional meta-analysis using summary statistics derived from published data (CMA), (ii) two-stage approach to IPD meta-analysis using summary statistics derived from IPD (IPDMA-2), and (iii) one-stage approach to IPD meta-analysis where IPD is pooled into a single data set (IPDMA-1) were compared.
RESULTS: In the conventional meta-analysis, only two of the six studies were included, because only these reported on relevant subgroup effects. The conventional meta-analysis showed larger (age < 2 years) or smaller (age > or = 2 years) subgroup effects and wider CIs than both IPD meta-analyses (age < 2 years: RDCMA -21 percent, RDIPDMA-1 -16 percent, RDIPDMA-2 -15 percent; age > or =2 years: RDCMA -5 percent, RDIPDMA-1 -11 percent, RDIPDMA-2 -11 percent). The most important reason for these discrepant results is that the two studies included in the conventional meta-analysis reported outcomes that were different both from each other and from the IPD meta-analyses.
CONCLUSIONS: This empirical example shows that conventional meta-analyses do not allow proper subgroup analyses, whereas IPD meta-analyses produce more accurate subgroup effects. We also found no differences between the one- and two-stage meta-analytic approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18601805     DOI: 10.1017/S0266462308080471

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  16 in total

1.  Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.

Authors:  Stefan Schandelmaier; Matthias Briel; Ravi Varadhan; Christopher H Schmid; Niveditha Devasenapathy; Rodney A Hayward; Joel Gagnier; Michael Borenstein; Geert J M G van der Heijden; Issa J Dahabreh; Xin Sun; Willi Sauerbrei; Michael Walsh; John P A Ioannidis; Lehana Thabane; Gordon H Guyatt
Journal:  CMAJ       Date:  2020-08-10       Impact factor: 8.262

2.  Aggregate-data estimation of an individual patient data linear random effects meta-analysis with a patient covariate-treatment interaction term.

Authors:  Stephanie A Kovalchik
Journal:  Biostatistics       Date:  2012-09-21       Impact factor: 5.899

3.  Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use.

Authors:  Jayne F Tierney; Claire Vale; Richard Riley; Catrin Tudur Smith; Lesley Stewart; Mike Clarke; Maroeska Rovers
Journal:  PLoS Med       Date:  2015-07-21       Impact factor: 11.069

Review 4.  Prognostic significance of overexpressed p16INK4a in patients with cervical cancer: a meta-analysis.

Authors:  Jiaying Lin; Andreas E Albers; Jinbao Qin; Andreas M Kaufmann
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

5.  Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ.

Authors:  Danielle L Burke; Joie Ensor; Richard D Riley
Journal:  Stat Med       Date:  2016-10-16       Impact factor: 2.373

6.  Understanding the relation between Zika virus infection during pregnancy and adverse fetal, infant and child outcomes: a protocol for a systematic review and individual participant data meta-analysis of longitudinal studies of pregnant women and their infants and children.

Authors:  Annelies Wilder-Smith; Yinghui Wei; Thalia Velho Barreto de Araújo; Maria VanKerkhove; Celina Maria Turchi Martelli; Marília Dalva Turchi; Mauro Teixeira; Adriana Tami; João Souza; Patricia Sousa; Antoni Soriano-Arandes; Carmen Soria-Segarra; Nuria Sanchez Clemente; Kerstin Daniela Rosenberger; Ludovic Reveiz; Arnaldo Prata-Barbosa; Léo Pomar; Luiza Emylce Pelá Rosado; Freddy Perez; Saulo D Passos; Mauricio Nogueira; Trevor P Noel; Antônio Moura da Silva; Maria Elisabeth Moreira; Ivonne Morales; Maria Consuelo Miranda Montoya; Demócrito de Barros Miranda-Filho; Lauren Maxwell; Calum N L Macpherson; Nicola Low; Zhiyi Lan; Angelle Desiree LaBeaud; Marion Koopmans; Caron Kim; Esaú João; Thomas Jaenisch; Cristina Barroso Hofer; Paul Gustafson; Patrick Gérardin; Jucelia S Ganz; Ana Carolina Fialho Dias; Vanessa Elias; Geraldo Duarte; Thomas Paul Alfons Debray; María Luisa Cafferata; Pierre Buekens; Nathalie Broutet; Elizabeth B Brickley; Patrícia Brasil; Fátima Brant; Sarah Bethencourt; Andrea Benedetti; Vivian Lida Avelino-Silva; Ricardo Arraes de Alencar Ximenes; Antonio Alves da Cunha; Jackeline Alger
Journal:  BMJ Open       Date:  2019-06-18       Impact factor: 2.692

Review 7.  Individual participant data meta-analyses compared with meta-analyses based on aggregate data.

Authors:  Catrin Tudur Smith; Maura Marcucci; Sarah J Nolan; Alfonso Iorio; Maria Sudell; Richard Riley; Maroeska M Rovers; Paula R Williamson
Journal:  Cochrane Database Syst Rev       Date:  2016-09-06

Review 8.  Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.

Authors:  Dipak Kotecha; Luis Manzano; Henry Krum; Giuseppe Rosano; Jane Holmes; Douglas G Altman; Peter D Collins; Milton Packer; John Wikstrand; Andrew J S Coats; John G F Cleland; Paulus Kirchhof; Thomas G von Lueder; Alan S Rigby; Bert Andersson; Gregory Y H Lip; Dirk J van Veldhuisen; Marcelo C Shibata; Hans Wedel; Michael Böhm; Marcus D Flather
Journal:  BMJ       Date:  2016-04-20

9.  β blockers for heart failure.

Authors:  Arno W Hoes
Journal:  BMJ       Date:  2016-04-20

Review 10.  Get real in individual participant data (IPD) meta-analysis: a review of the methodology.

Authors:  Thomas P A Debray; Karel G M Moons; Gert van Valkenhoef; Orestis Efthimiou; Noemi Hummel; Rolf H H Groenwold; Johannes B Reitsma
Journal:  Res Synth Methods       Date:  2015-08-19       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.